These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8973352)

  • 1. A recombinant, arginine-glycine-aspartic acid (RGD) motif from foot-and-mouth disease virus binds mammalian cells through vitronectin and, to a lower extent, fibronectin receptors.
    Villaverde A; Feliu JX; Harbottle RP; Benito A; Coutelle C
    Gene; 1996 Nov; 180(1-2):101-6. PubMed ID: 8973352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell recognition by foot-and-mouth disease virus that lacks the RGD integrin-binding motif: flexibility in aphthovirus receptor usage.
    Baranowski E; Ruiz-Jarabo CM; Sevilla N; Andreu D; Beck E; Domingo E
    J Virol; 2000 Feb; 74(4):1641-7. PubMed ID: 10644333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arginine-glycine-aspartic acid-specific binding by foot-and-mouth disease viruses to the purified integrin alpha(v)beta3 in vitro.
    Jackson T; Sharma A; Ghazaleh RA; Blakemore WE; Ellard FM; Simmons DL; Newman JW; Stuart DI; King AM
    J Virol; 1997 Nov; 71(11):8357-61. PubMed ID: 9343190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to the vitronectin receptor (integrin alpha V beta 3) inhibit binding and infection of foot-and-mouth disease virus to cultured cells.
    Berinstein A; Roivainen M; Hovi T; Mason PW; Baxt B
    J Virol; 1995 Apr; 69(4):2664-6. PubMed ID: 7533862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Foot-and-mouth disease virus is a ligand for the high-affinity binding conformation of integrin alpha5beta1: influence of the leucine residue within the RGDL motif on selectivity of integrin binding.
    Jackson T; Blakemore W; Newman JW; Knowles NJ; Mould AP; Humphries MJ; King AM
    J Gen Virol; 2000 May; 81(Pt 5):1383-91. PubMed ID: 10769082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid).
    Fox G; Parry NR; Barnett PV; McGinn B; Rowlands DJ; Brown F
    J Gen Virol; 1989 Mar; 70 ( Pt 3)():625-37. PubMed ID: 2543752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic properties and population stability of a foot-and-mouth disease virus with an altered Arg-Gly-Asp receptor-recognition motif.
    Ruiz-Jarabo CM; Sevilla N; Dávila M; Gómez-Mariano G; Baranowski E; Domingo E
    J Gen Virol; 1999 Aug; 80 ( Pt 8)():1899-1909. PubMed ID: 10466785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrin alphavbeta1 is a receptor for foot-and-mouth disease virus.
    Jackson T; Mould AP; Sheppard D; King AM
    J Virol; 2002 Feb; 76(3):935-41. PubMed ID: 11773368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient accommodation of recombinant, foot-and-mouth disease virus RGD peptides to cell-surface integrins.
    Alcalá P; Feliu JX; Arís A; Villaverde A
    Biochem Biophys Res Commun; 2001 Jul; 285(2):201-6. PubMed ID: 11444826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific interactions between human integrin alpha v beta 3 and chimeric hepatitis B virus core particles bearing the receptor-binding epitope of foot-and-mouth disease virus.
    Sharma A; Rao Z; Fry E; Booth T; Jones EY; Rowlands DJ; Simmons DL; Stuart DI
    Virology; 1997 Dec; 239(1):150-7. PubMed ID: 9426454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RGD sequence of foot-and-mouth disease virus is essential for infecting cells via the natural receptor but can be bypassed by an antibody-dependent enhancement pathway.
    Mason PW; Rieder E; Baxt B
    Proc Natl Acad Sci U S A; 1994 Mar; 91(5):1932-6. PubMed ID: 8127909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human integrin alpha 8 beta 1 functions as a receptor for tenascin, fibronectin, and vitronectin.
    Schnapp LM; Hatch N; Ramos DM; Klimanskaya IV; Sheppard D; Pytela R
    J Biol Chem; 1995 Sep; 270(39):23196-202. PubMed ID: 7559467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-efficiency utilization of the bovine integrin alpha(v)beta(3) as a receptor for foot-and-mouth disease virus is dependent on the bovine beta(3) subunit.
    Neff S; Mason PW; Baxt B
    J Virol; 2000 Aug; 74(16):7298-306. PubMed ID: 10906183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RGD-mutants of B-lymphotropic polyomavirus capsids specifically bind to alpha(v)beta3 integrin.
    Langner J; Neumann B; Goodman SL; Pawlita M
    Arch Virol; 2004 Oct; 149(10):1877-96. PubMed ID: 15290355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The epithelial integrin alphavbeta6 is a receptor for foot-and-mouth disease virus.
    Jackson T; Sheppard D; Denyer M; Blakemore W; King AM
    J Virol; 2000 Jun; 74(11):4949-56. PubMed ID: 10799568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis of ligand recognition by integrin alpha 5beta 1. I. Specificity of ligand binding is determined by amino acid sequences in the second and third NH2-terminal repeats of the alpha subunit.
    Mould AP; Askari JA; Humphries MJ
    J Biol Chem; 2000 Jul; 275(27):20324-36. PubMed ID: 10764748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of a foot-and-mouth disease virus type A24 isolate containing an SGD receptor recognition site in vitro and its pathogenesis in cattle.
    Rieder E; Henry T; Duque H; Baxt B
    J Virol; 2005 Oct; 79(20):12989-98. PubMed ID: 16189001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propagation of an attenuated virus by design: engineering a novel receptor for a noninfectious foot-and-mouth disease virus.
    Rieder E; Berinstein A; Baxt B; Kang A; Mason PW
    Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10428-33. PubMed ID: 8816817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Foot-and-mouth disease virus can utilize the C-terminal extension of coxsackievirus A9 VP1 for cell infection.
    Leippert M; Pfaff E
    J Gen Virol; 2001 Jul; 82(Pt 7):1703-1711. PubMed ID: 11413382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitronectin receptor antibodies inhibit infection of HeLa and A549 cells by adenovirus type 12 but not by adenovirus type 2.
    Bai M; Campisi L; Freimuth P
    J Virol; 1994 Sep; 68(9):5925-32. PubMed ID: 7520097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.